| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72603-171-01 | 72603-171 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | POWDER, FOR SUSPENSION | ORAL | 20230907 | N/A | ANDA | ANDA215043 | NorthStar Rx LLC | FAMOTIDINE | 40 mg/5mL | 50 mL in 1 BOTTLE (72603-171-01) |
| 51407-452-50 | 51407-452 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | POWDER, FOR SUSPENSION | ORAL | 20210519 | N/A | ANDA | ANDA215043 | Golden State Medical Supply, Inc. | FAMOTIDINE | 40 mg/5mL | 50 mL in 1 BOTTLE (51407-452-50) |
| 70954-316-10 | 70954-316 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | POWDER, FOR SUSPENSION | ORAL | 20210420 | N/A | ANDA | ANDA215043 | ANI Pharmaceuticals, Inc. | FAMOTIDINE | 40 mg/5mL | 50 mL in 1 BOTTLE (70954-316-10) |